GlassScriptPhysician profile
Charmi Patel
NPI 1518364512
$3,254.48
in general payments reported to CMS, 2019-2025
17 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $496 · 2024: $1,673 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,185 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.49 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $547.44 | 2023-2025 | Opzelura, Iclusig |
| Verrica Pharmaceuticals INC. | $471.67 | 2023-2025 | Ycanth |
| Abbvie INC. | $455.69 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $332.53 | 2024-2025 | Zoryve |
| Janssen Biotech, INC. | $250.05 | 2023-2025 | Tremfya |
| Genzyme Corporation | $181.83 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $178.93 | 2023-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $171.28 | 2023-2025 | |
| Dermavant Sciences, INC. | $131.90 | 2024 | Vtama |
| Ucb, INC. | $116.99 | 2023-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $114.32 | 2024 | Sotyktu |
| Amgen INC. | $111.71 | 2024-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $55.80 | 2024-2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $50.79 | 2025 | |
| Lilly USA, LLC | $48.66 | 2025 | Ebglyss, Taltz |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $32.79 | 2025 | Vtama, Nexplanon |
| Biofrontera INC. | $2.10 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charmi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.